Clinical Trials Directory

Trials / Completed

CompletedNCT07469254

Adding 1% Metformin Gel to Bone Graft in Association With Immediate Dental Implants

The Impact of Adding 1% Metformin Gel to Bone Graft in Association With Immediate Dental Implants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Al-Azhar University · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

This study aimed to investigate whether combining xenografts with Metformin Gel gel enhances bone regeneration and improves implant outcomes.

Detailed description

The placement of a dental implant in an extraction socket at the time of extraction or explanation is known as immediate implant placement whereas delayed placement of implant signifies the implant placement in edentulous areas where healing has completed with new bone formation after the loss of tooth/teeth. The xenograft is derived from other organisms, mainly bovine. It provides long-term volume stability. Porous natural hydroxyapatite can be obtained from animal bones. Metformin HCl (1, 1-dimethylbiguanide HCl) (MF), is one of the most commonly used oral anti-hyperglycemic agents for the treatment of type 2 diabetes mellitus. The use of MF may reduce the association between diabetes and fractures in patients with both type 1 and type 2DM.MF increase type I collagen production in osteoblast-like cell lines and stimulated alkaline phosphate activity in osteoblasts.

Conditions

Interventions

TypeNameDescription
OTHERMetformin gel-xenograftPatients received immediate implant combined with a mixture of 1%metformin gel and xenograft.
OTHERXenograftPatients received immediate implant combined with xenograft alone.

Timeline

Start date
2022-11-01
Primary completion
2025-09-01
Completion
2025-09-01
First posted
2026-03-13
Last updated
2026-03-13

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07469254. Inclusion in this directory is not an endorsement.